Aufman Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $605K | Buy |
3,262
+1
| +0% | +$186 | 0.37% | 27 |
|
|
2025
Q1 | $683K | Sell |
3,261
-70
| -2% | -$14.7K | 0.47% | 23 |
|
|
2024
Q4 | $592K | Hold |
3,331
| – | – | 0.4% | 24 |
|
|
2024
Q3 | $658K | Buy |
3,331
+870
| +35% | +$172K | 0.42% | 23 |
|
|
2024
Q2 | $422K | Hold |
2,461
| – | – | 0.3% | 25 |
|
|
2024
Q1 | $448K | Hold |
2,461
| – | – | 0.32% | 25 |
|
|
2023
Q4 | $381K | Buy |
2,461
+1
| +0% | +$155 | 0.29% | 26 |
|
|
2023
Q3 | $367K | Sell |
2,460
-55
| -2% | -$8.2K | 0.31% | 27 |
|
|
2023
Q2 | $339K | Sell |
2,515
-153
| -6% | -$20.6K | 0.28% | 28 |
|
|
2023
Q1 | $425K | Sell |
2,668
-67
| -2% | -$10.7K | 0.36% | 25 |
|
|
2022
Q4 | $442K | Sell |
2,735
-20
| -0.7% | -$3.23K | 0.41% | 21 |
|
|
2022
Q3 | $370K | Sell |
2,755
-149
| -5% | -$20K | 0.39% | 24 |
|
|
2022
Q2 | $445K | Sell |
2,904
-225
| -7% | -$34.5K | 0.42% | 22 |
|
|
2022
Q1 | $507K | Sell |
3,129
-110
| -3% | -$17.8K | 0.4% | 22 |
|
|
2021
Q4 | $439K | Buy |
3,239
+21
| +0.7% | +$2.85K | 0.32% | 26 |
|
|
2021
Q3 | $347K | Hold |
3,218
| – | – | 0.29% | 26 |
|
|
2021
Q2 | $362K | Buy |
3,218
+118
| +4% | +$13.3K | 0.28% | 26 |
|
|
2021
Q1 | $335K | Hold |
3,100
| – | – | 0.28% | 26 |
|
|
2020
Q4 | $332K | Hold |
3,100
| – | – | 0.3% | 26 |
|
|
2020
Q3 | $272K | Sell |
3,100
-103
| -3% | -$9.04K | 0.29% | 29 |
|
|
2020
Q2 | $314K | Hold |
3,203
| – | – | 0.36% | 26 |
|
|
2020
Q1 | $244K | Hold |
3,203
| – | – | 0.34% | 33 |
|
|
2019
Q4 | $284K | Buy |
+3,203
| New | +$284K | 0.29% | 33 |
|